期刊文献+

参灵扶正胶囊治疗HIV感染者的临床研究 被引量:3

Clinical study on Shen Ling Fuzheng Capsule in the treatment of HIV infected patients
下载PDF
导出
摘要 目的观察参灵扶正胶囊治疗气虚型HIV感染者的临床疗效。方法采用参灵扶正胶囊治疗气虚型HIV感染者380例,疗程1年,观察指标有临床症状、体征总积分、卡洛夫斯基积分,以及CD4+细胞计数及生存质量的变化情况。结果治疗后感染者症状、体征总积分、卡洛夫斯基积分及CD4+稳定率分别为94.74%、83.95%、96.6%,临床症状、体征总积分和卡洛夫斯基积分,CD4+细胞计数,生存质量中生理领域、心理领域、社会关系及总积分改善显著(P<0.05或P<0.01)。结论参灵扶正胶囊可显著改善气虚型HIV感染者的临床症状和体征,提高感染者的生存质量,对部分感染者的免疫功能有提高或稳定作用。 Objective To investigate the clinical efficacy of Shen Ling Fuzheng Capsule in the treat- ment of HIV infected patients of Qi deficiency. Method 380 cases of HIV infected patients of Qi defi- ciency were treated with Shen Ling Fuzheng Capsule for a course of 1 year. The observation index included score of clinical symptoms and signs, Karnovski score, CIM cell count, and quality of life(QOL) before and after treatment. Results The HIV-infected persons' stability rate of score of clinical symptoms and signs, Karnovski, CIM cell count were 94.74%, 83.95%, and 96.6% after treatment , respectively. Score of clinical symptoms and signs, Karnovski score, CIM cell count, and QOL improved significantly after treatment( P 〈 0.05 or P 〈 0.01 ). Conclusion Shen Ling Fuzheng Capsule can significantly improve clinical symptoms and signs and the quality of life of those HIV-infected persons, and can improve or stabilize immunization function in part of the HIV infected patients.
出处 《微创医学》 2013年第3期253-255,266,共4页 Journal of Minimally Invasive Medicine
基金 国家科技重大专项课题(合同号:2012ZX10005010-004) 广西科技厅攻关课题(桂科攻1355005-1-4 1298003-1-1 11107009-1-3) 广西自然基金课题(合同号:08320162) 广西中医药管理局科技专项(GZZY13-24 GZPT1223 GZYZ-10-12 GZKZ10-054 GZYZ-10-14)
关键词 HIV感染 参灵扶正胶囊 临床观察 疗效 HIV infection Shen Ling Fuzheng Capsule Clinical observation Efficacy
  • 相关文献

参考文献13

二级参考文献60

  • 1万崇华,方积乾,汤学良,张灿珍,卢玉波,孟琼,高丽.SF-36量表用于肝癌患者生活质量测定的效果评价[J].肿瘤,2005,25(5):492-494. 被引量:92
  • 2王爱霞,王福生,王清玥,王健,冯铁建,卢洪洲,孙洪清,孙永涛,叶寒辉,李太生,李兴旺,刘正印,邢玉兰,何云,汪宁,吴昊,吴南屏,张福杰,周曾全,宫恩聪,赵红心,赵敏,唐小平,徐莲芝,徐小元,曹韵贞,康来仪,蒋岩,蔡卫平,樊庆泊,潘孝彰.艾滋病诊疗指南[J].中华传染病杂志,2006,24(2):133-144. 被引量:632
  • 3国家中医药管理局.5省中医药治疗艾滋病项目临床技术方案.,2004.5~9.
  • 4中华人民共和国卫生部、中华医学会.艾滋病诊疗指南.,2004.3~5.
  • 5UNAIDS. AIDS epidemic update: December 2007. March 2008. http://www, unaids, org/en/KnowledgeCentre/ HIVData/EpiUpdate/EpiUpdArchive/2007/default. asp (accessed Oct 21, 2009).
  • 6Levy JA. HIV and the Pathogenesis of AIDS. 2rd ed. Washington, DC: ASM Press, 1988.
  • 7John G, Bartlett MD, Joel E,et al. Medical Management of HIV Infection. 2004.
  • 8Barr4-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquiredimmune deficiency syndrome (AIDS). Seience, 1983,220:868-871.
  • 9Graf M, Shao Y, Zhao Q,et al. Cloning and characterization of a virtually full-length HIV type 1 genome from a subtypeB- Thai strain representing the most prevalent B clade isolate in China. AIDSRes HumRetroviruses, 1998,14:285-288.
  • 10中国疾病预防控制中心.全国艾滋病检测技术规范.2004年8月.

共引文献338

同被引文献53

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部